codiagnostics.com - CODX Company Value to Revenue Ratio

Public company logo of Co-Diagnostics (CODX)

Co-Diagnostics, Inc. generates revenue from the supply of PCR systems and DNA analyzers to global clinics. The enterprise value-to-revenue ratio reflects market sentiment, where 3969.23 indicates the current value of this metric. The molecular center in Utah is scaling test production through external partners. A high degree of sequencing automation and bioinformatics ensure autonomous data processing.

CODX Co-Diagnostics Corp: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

CODX (Co-Diagnostics, Inc.): analytical breakdowns and indicator data

Initial company analysis:CODX, codiagnostics.com
Signature product of CoDx

The scale of Co-Diagnostics, Inc. (CODX) business and its patent-protected PCR technologies determine the current EV/Sales valuation at 3969.23. This ratio compares the total enterprise value to annual revenue regardless of debt load, measuring market equilibrium and management's ability to maintain capitalization amidst high regulatory barriers to entry in the molecular diagnostics sector.

Competitor analysis

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue